Trial
NCT01962948
Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Fox Chase Cancer Center
Collaborators
National Cancer Institute (NCI)
Condition
Recurrent Fallopian Tube Cancer
Intervention
paclitaxel
Why stopped
Study drug is no longer supplied by grantor.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-26